BioProcess International Europe is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Jim Fries is a success based executive with over 25 years of experience building medical device and diagnostic companies from a sales, market access, and external validation standpoint. Jim became CEO of Rx-360 in February of 2018, as a way of fulfilling his personal lifelong commitment to patient safety. Prior to coming to Rx-360 Jim was the CEO of OrthoForge, in which he led the the company through their early stage of fundraising, product development, FDA pathway, and strategic collaboration initiatives.
Jim’s strategic vision, fit well with the Rx-360 Mission of supply chain security and pateint safety. His roll up the sleeves mentality, is creative and has been proven as a best practice in achieving both short and long term goals. Jim’s leadership style has consistently been described as collaborative, mentoring, and accountable.
Jim, has successfully built and managed multiple teams and organizations that have exceeded growth expectations. He has successfully developed and integrated not only customer retension and acqusition programs but also built sales, regulatory, clinical, and market access teams for multiple organizations. Jim has also managed key opinion leader and advisory boards for multiple companies which resulted in published concensus papers and treatment guidleines. His formal collaborations both commercially and development (OEM and R&D) wise within multiple product and disease states have been benchmarks in driving value within growth oriented companies